The 2018 Miami Breast Cancer Conference (March 8-11) offered insight into the optimal multidisciplinary management of patients with breast cancer.
Significant advances have elevated breast cancer care to new levels of success and complexity. One such advance has been the availability of CDK 4/6 inhibitors in women with estrogen receptor-positive (ER+) metastatic breast cancer.
This Expert Perspectives activity features the clinical faculty from a symposium held at the 2016 Annual Meeting of the Oncology Nursing Society sharing highlights from the symposium and additional relevant clinical commentary.
This webcast features Chair, Kathy S. Albain, MD, FACP, FASCO discussing highlights from the 13th Annual Best of San Antonio - Breast Cancer: Bench to Bedside.